glp-1 diarrhea and vomiting Overdose risks increase as demand for injectable weight-loss drugs on the rise, research finds Glucagon-like Peptide-1 Receptor Agonists Associated

Food and Drug Administration in mid-2022, Mounjaro generated $5.2 billion in sales worldwide in 2023, and that jumped to $11.5 billion in 2024

Tirzepatide Injection $249/mo

doi: 10.1007/s00125-012-2459-7

But in Indian practice, they are often added on top of: Sulfonylureas (like glimepiride, gliclazide) Or insulin If the doses of these older drugs are not reduced when appetite drops, the combination can lead to dangerous blood sugar dips in patients who are now eating much less

Approved in 1964 for the management of hypertension, propranolol is now used for a wide range of cardiovascular diseases, including ischemic heart disease, angina pectoris, arrhythmias, and myocardial infarction, as well as non cardiovascular conditions, including migraine, tremors and anxiety

That is real, and it should not be dismissed